1. Yusuf S, Hawken S, Ounpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952
2. Voight BF, Peloso GM, Orho-Melander M et al (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380:572–580
3. Carroll MD, Kit BK, Lacher DA (2012) Total and high-density lipoprotein cholesterol in adults: National Health and Nutrition Examination Survey, 2009–2010. NCHS Data Brief (92):1–8
4. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2006) Nationale VersorgungsLeitlinie Chronische KHK – Langfassung. Version 1.13. 2006 (cited: 18.10.2012). http://www.versorgungsleitlinien.de. doi:10.6101/AZQ/000041
5. Cooper A, Nherera L, Calvert N et al (2008) Clinical guidelines and evidence review for lipid modification: cardiovascular risk assessment and the primary and secondary prevention of cardiovascular disease London. National Collaborating Centre for Primary Care and Royal College of General Practitioners